These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma. Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936 [TBL] [Abstract][Full Text] [Related]
8. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]
9. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas. Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of conjunctival nevi and melanomas. Jakobiec FA; Bhat P; Colby KA Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539 [TBL] [Abstract][Full Text] [Related]
12. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases. Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332 [TBL] [Abstract][Full Text] [Related]
13. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi. Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673 [TBL] [Abstract][Full Text] [Related]
14. Cathepsin K in the immunohistochemical diagnosis of melanocytic lesions. Rao Q; Wang Y; Xia QY; Shi SS; Shen Q; Tu P; Shi QL; Zhou XJ; Wu B Int J Clin Exp Pathol; 2014; 7(3):1132-9. PubMed ID: 24696729 [TBL] [Abstract][Full Text] [Related]
15. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831 [TBL] [Abstract][Full Text] [Related]
16. Observational Study Examining the Diagnostic Practice of Ki67 Staining for Melanocytic Lesions. Vyas NS; Charifa A; Desman GT; Goldberg M; Singh R; Phelps RG; McNiff JM Am J Dermatopathol; 2019 Jul; 41(7):488-491. PubMed ID: 31233404 [TBL] [Abstract][Full Text] [Related]
17. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977 [TBL] [Abstract][Full Text] [Related]
18. Fascin expression in melanocytic lesions of the skin. YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987 [TBL] [Abstract][Full Text] [Related]
19. Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions. Chorny JA; Barr RJ; Kyshtoobayeva A; Jakowatz J; Reed RJ Mod Pathol; 2003 Jun; 16(6):525-9. PubMed ID: 12808056 [TBL] [Abstract][Full Text] [Related]
20. A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53. Väisänen A; Kuvaja P; Kallioinen M; Turpeenniemi-Hujanen T Hum Pathol; 2011 Aug; 42(8):1103-11. PubMed ID: 21334717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]